The type facet of market taxonomy classifies Biological Sensors into electrochemical, optical, mass‑based, and piezoelectric families, each with distinct sub‑technologies. Electrochemical sensors—sub‑divided into amperometric, potentiometric, and conductometric—dominate due to low power consumption and compatibility with miniaturized electronics, especially in glucose and lactate monitoring. Optical sensors encompass fluorescence, surface plasmon resonance, and interferometric variants, offering high sensitivity for immunoassays and environmental analytes but at higher cost. Mass‑based platforms, such as quartz crystal microbalance and cantilever sensors, excel in label‑free detection of biomolecular interactions, appealing to pharmaceutical screening. Piezoelectric sensors, including surface acoustic wave devices, provide rapid response for gas‑phase sensing in environmental contexts. The relative share of each type is dictated by performance criteria—sensitivity, selectivity, form‑factor—and end‑user cost constraints, collectively defining the market’s technology adoption curve.